(Q46446352)

22 December 2017

title

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors (English)

1 reference

22 December 2017

0 references

0 references

Taku Nagai

1

1 reference

22 December 2017

Rina Murai

2

1 reference

22 December 2017

Kanae Matsui

3

1 reference

22 December 2017

Hiroyuki Kamei

4

1 reference

22 December 2017

Yukihiro Noda

5

1 reference

22 December 2017

Hiroshi Furukawa

6

1 reference

22 December 2017

Toshitaka Nabeshima

7

1 reference

22 December 2017

publication date

6 August 2008

1 reference

22 December 2017

published in

Psychopharmacology

1 reference

22 December 2017

volume

202

1 reference

22 December 2017

issue

1-3

1 reference

22 December 2017

page(s)

315-328

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-008-1240-6

exact match

0 references

cites work

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

Prolonged psychosis attributed to phencyclidine: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1240-6

A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2.

21 January 2018

1 reference

12 December 2020

Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation

1 reference

12 December 2020

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

1 reference

12 December 2020

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

12 December 2020

Identification of separable cognitive factors in schizophrenia

1 reference

12 December 2020

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

1 reference

12 December 2020

Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

1 reference

12 December 2020

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

12 December 2020

Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system

1 reference

12 December 2020

Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset.

1 reference

12 December 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

12 December 2020

Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.

1 reference

12 December 2020

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

1 reference

12 December 2020

Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress.

1 reference

12 December 2020

Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.

1 reference

12 December 2020

Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Neurobiology of schizophrenia

1 reference

12 December 2020

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

12 December 2020

THE SYNTHESIS OF PHENCYCLIDINE AND OTHER 1-ARYLCYCLOHEXYLAMINES.

1 reference

12 December 2020

High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study

1 reference

12 December 2020

The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice

1 reference

12 December 2020

Legal issues associated with PCP abuse--the role of the forensic expert.

1 reference

12 December 2020

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

12 December 2020

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

1 reference

12 December 2020

The neurobiology of cognition in schizophrenia.

1 reference

12 December 2020

Focus on aripiprazole

1 reference

12 December 2020

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain

1 reference

12 December 2020

Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice.

1 reference

12 December 2020

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

1 reference

12 December 2020

Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist

1 reference

12 December 2020

Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions

1 reference

12 December 2020

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

1 reference

12 December 2020

Genetic enhancement of learning and memory in mice

1 reference

12 December 2020

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

1 reference

12 December 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

12 December 2020

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

12 December 2020

Dissociation in prefrontal cortex of affective and attentional shifts

1 reference

12 December 2020

Partial dopamine agonists in the treatment of psychosis

1 reference

12 December 2020

Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies

1 reference

12 December 2020

Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

12 December 2020

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

12 December 2020

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

12 December 2020

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

12 December 2020

Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex

1 reference

12 December 2020

Long-lasting impairment of associative learning is correlated with a dysfunction of N-methyl-D-aspartate-extracellular signaling-regulated kinase signaling in mice after withdrawal from repeated administration of phencyclidine

1 reference

12 December 2020

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia

1 reference

12 December 2020

Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland

1 reference

12 December 2020

Size of burden of schizophrenia and psychotic disorders

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

12 December 2020

Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex

1 reference

12 December 2020

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

1 reference

12 December 2020

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

1 reference

12 December 2020

Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex

1 reference

12 December 2020

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

12 December 2020

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

1 reference

12 December 2020

10.1007/S00213-008-1240-6

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017